Focus |

Cell therapies

For cell therapies to transition from promises to products, increased efforts need to be put into the identification of the factors and biological mechanisms that affect safety and efficacy, and into the design of cost-effective methods for the harvesting, expansion, manipulation and purification of the cells.

This focus provides an overview of the state of the art of cell therapies, with emphasis on cardiac regenerative medicine and immunotherapy, and explores the challenges that lie ahead.

See all Collections from Nature Biomedical Engineering.

Reviews

This Review Article provides an overview of chimeric antigen receptors (CARs) for T cells and discusses engineering strategies for the design of next-generation CAR-T therapies for haematologic and solid cancers.

Review Article | | Nature Biomedical Engineering

News & Comment

For cell therapies to transition from promises to products, increased efforts need to be put into the identification of the factors and biological mechanisms that affect safety and efficacy, and into the design of cost-effective methods for the harvesting, expansion, manipulation and purification of the cells.

Editorial | | Nature Biomedical Engineering

Articles